Skip to content

89bio vs HighTide Therapeutics

89bio logo

89bio

Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases

123 employees · est. 2018 · San Francisco, United States

VS
HighTide Therapeutics logo

HighTide Therapeutics

East Meets West—The Quest for Cure

18 employees · est. 2011 · Shenzhen, China

HighTide Therapeutics is the older company (2018 vs 2011); 89bio is the larger of the two.

Side-by-Side Comparison

89bio HighTide Therapeutics
Founded
2018 2011 older
Headquarters
San Francisco, United States Shenzhen, China
Employees
123 larger 18
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Post-IPO Equity Series C
Total Funding
$773.20M $107.00M
Funding Rounds
7 1
Taxonomy
Biopharmaceutical CompanyClinical-stageFGF21 AnalogNASH TreatmentSHTG TreatmentLiver Diseases +9 Biopharmaceutical CompanyMultifunctional TherapiesMetabolic DiseasesDigestive DiseasesNASH TreatmentType 2 Diabetes Treatment +9
Website
89bio.com hightidetx.com
89bio logo

About 89bio

89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment...

HighTide Therapeutics logo

About HighTide Therapeutics

HighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company founded in 2011, based in China. The company's mission revolves around the development of innovative multifunctional therapies for metabolic and digestive diseases, aiming to address significant unmet medical ne...

Also comparing in this category

Comparing more than these two?

Get 89bio, HighTide Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does 89bio compare?

A PDF of 89bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

89bio was founded in 2018, based in San Francisco, United States, with 123 employees. 89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead produ. HighTide Therapeutics was founded in 2011, based in Shenzhen, China, with 18 employees. HighTide Therapeutics, Inc. (2511.HK) is a globally integrated biopharmaceutical company founded in 2011, based in China. The company's mission revolves around the development of innovative multifunct.
89bio has raised $773.20M and HighTide Therapeutics $107.00M. Latest stage: 89bio Post-IPO Equity, HighTide Therapeutics Series C.
Both work in Biotechnology and Pharmaceutical and list biopharmaceutical company and nash treatment among their focus areas.

Compare 89bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at 89bio on 9 Jun 2026, and HighTide Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout